PEPG

$1.84-0.08 (-4.40%)

After Hours$1.84+0.00 (+0.00%)· Last close May 6

PepGen Inc., a clinical-stage biotechnology company, develops oligonucleotide therapeutics for the treatment of severe neuromuscular and neurologic diseases in the United States.

Overview Intraday ResearchPRO BacktestPRO Ask AIPRO TranscriptsPRO StatementsPRO